• Seen in patients treated for lymphoma, breast cancer, and lung
cancer.
• Cardiac injury:
• Myocardium
• Vascular endothelium and capillary vessels
• The relationship between dose to
cardiac substructures
and
subsequent toxicity has not been well defined.
CARDIAC TOXICITY